High incidence of thrombotic events observed in patients receiving lenalidomide (L) + dexamethasone (D) (LD) as first-line therapy for multiple myeloma (MM) without aspirin (ASA) prophylaxis [abstract 3455] - Zonder, JA; Durie, BGM; McCoy, J (Blood, 2005)
et al.